1. In silico prediction of T‐cell and B‐cell epitopes of human papillomavirus type 16 L1 protein
   Shahab Mahmoudvand et al, 2022, Biotechnology and Applied Biochemistry CrossRef
2. Prevalence of antibodies against a cyclic peptide mimicking the FG loop of the human papillomavirus type 16 capsid among Tunisian women
   Elham Hassen et al, 2020, Journal of Translational Medicine CrossRef
3. Proposal for cervical cancer screening in the era of HPV vaccination
   Yung-Taek Ouh et al, 2018, Obstetrics & Gynecology Science CrossRef
4. The Rationale for a Preventative HCV Virus-Like Particle (VLP) Vaccine
   Joseph Torresi, 2017, Frontiers in Microbiology CrossRef
5. Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
   Igor Radanovic et al, 2022, Frontiers in Oncology CrossRef
6. Screening and identification of B cell epitope within the major capsid protein L1 of HPV 52, using monoclonal antibodies
   Yumei Chen et al, 2024, Journal of Virological Methods CrossRef